Insider · CIK 0001830363

Renger John

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001830363

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−6,370 sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−778K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−15.1K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−87.6K sh	—	—	0
2024-02-07	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−2,161 sh	$41.54	−$89.8K	6,370
2024-02-06	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,020 sh	—	—	8,531
2024-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,020 sh	—	—	15,061
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+87.6K sh	—	—	87,573
2023-02-06	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+79K sh	—	—	79,022
2023-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Scientific Officer	AAward	+20.1K sh	—	—	20,081
2022-11-01	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.50	+$35.1K	12,722
2022-11-01	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+15K sh	$10.28	+$154K	27,704
2022-11-01	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$30.00	−$750K	2,704
2022-11-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	60,110
2022-11-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−15K sh	—	—	104,951
2022-10-04	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.50	+$35.1K	12,722
2022-10-04	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+15K sh	$10.28	+$154K	27,704
2022-10-04	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$30.00	−$750K	2,704
2022-10-04	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	70,128
2022-10-04	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−15K sh	—	—	119,933
2022-08-10	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+29.6K sh	$3.50	+$104K	32,328
2022-08-10	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+25.4K sh	$10.28	+$261K	57,704
2022-08-10	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−36.1K sh	$40.19	−$1.45M	21,563
2022-08-10	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−18.9K sh	$41.10	−$775K	2,704
2022-08-10	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−29.6K sh	—	—	80,146
2022-08-10	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−25.4K sh	—	—	134,915
2022-08-08	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.50	+$35K	12,704
2022-08-08	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$37.75	−$378K	2,704
2022-08-08	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	109,770
2022-08-05	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$3.50	+$70K	22,704
2022-08-05	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−20K sh	$32.50	−$650K	2,704
2022-08-05	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	119,770
2022-07-20	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+25K sh	$3.50	+$87.5K	27,704
2022-07-20	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$30.00	−$750K	2,704
2022-07-20	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−25K sh	—	—	139,770
2022-07-06	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+1,105 sh	$3.50	+$3,867.5	3,809
2022-07-06	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−1,105 sh	$32.50	−$35.9K	2,704
2022-07-06	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−1,105 sh	—	—	164,770
2022-07-05	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+25K sh	$3.50	+$87.5K	27,704
2022-07-05	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−25K sh	$30.00	−$750K	2,704
2022-07-05	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−25K sh	—	—	165,875
2022-04-13	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+45K sh	$3.50	+$158K	46,980
2022-04-13	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−45K sh	$34.65	−$1.56M	1,980
2022-04-13	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−45K sh	—	—	190,875
2022-03-29	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+10K sh	$3.50	+$35K	11,980
2022-03-29	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−10K sh	$35.00	−$350K	1,980
2022-03-29	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−10K sh	—	—	235,875
2022-03-18	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20K sh	$3.50	+$70K	21,980
2022-03-18	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Scientific Officer	SSale	−20K sh	$32.50	−$650K	1,980
2022-03-18	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20K sh	—	—	245,875

Recent filings

Accepted (ET)
Aug 54
Renger John0000950170-24-090830
SEC(opens sec.gov)
Feb 84
Renger John0000950170-24-012962
SEC(opens sec.gov)
Jan 234
Renger John0000950170-24-006704
SEC(opens sec.gov)
Feb 84
Renger John0000899243-23-004366
SEC(opens sec.gov)
Nov 34
Renger John0000899243-22-034915
SEC(opens sec.gov)
Oct 64
Renger John0000899243-22-033167
SEC(opens sec.gov)

Companies

Cerevel Therapeutics Holdings, Inc.Chief Scientific Officer

Address

C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET, SUITE 502

BOSTON, MA, 02116